Status:

COMPLETED

Comparison of the FemoSeal® Arterial Closure Device to Manual Compression After Coronary Angiography

Lead Sponsor:

Aarhus University Hospital Skejby

Collaborating Sponsors:

Vingmed Danmark A/S

Conditions:

Coronary Angiography Via Femoral Artery Access

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Is the FemoSeal® closure device safer and more comfortable than manual compression for femoral artery access closure after coronary angiography?

Detailed Description

Access site complication after coronary angiography is still a challenge in everyday practice. The FemoSeal® closure device has proven very safe as shown in the swedish SCAAR registry. This study is a...

Eligibility Criteria

Inclusion

  • The patient must be at least 18 years old
  • Patients undergoing femoral access coronary angiography
  • Patient must be competent for providing informed, written consent
  • Only 6F sheath

Exclusion

  • Percutaneous coronary intervention
  • Intra coronary measurements (FFR, IVUS, OCT, NIR)
  • Groin hematoma before closure
  • Pseudoaneurysm or AV fistula
  • Significant stenosis of ilial or femoral artery
  • Prior peripheral artery surgery
  • INR \> 3,0
  • Platelet count \< 120 million per millilitre blood
  • Coagulopathy (bleeding disorder)
  • Thrombolysis in the last 24h
  • Planned heparin infusion after the procedure
  • Pregnancy
  • Uncontrolled hypertension \> 200 mmHg / 110 mmHg
  • Femoral access device closure in the last 30 days

Key Trial Info

Start Date :

September 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2010

Estimated Enrollment :

1005 Patients enrolled

Trial Details

Trial ID

NCT01001663

Start Date

September 1 2009

End Date

September 1 2010

Last Update

January 2 2026

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Aarhus University Hospital Skejby

Aarhus N, Denmark, 8200